 "Domestic drugmakers")
US researchers who tested the cancer-fighting properties of more than 4,500 non-cancer drugs found nearly 50 drugs for other conditions showed at least some cancer-killing ability.
“We found that a surprising number of non-oncology drugs are able to kill cancer cell lines in the lab,” said Steven Corsello of Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard University, who led the research.
Bruce Bloom of Cambridge, Massachusetts-based Healx, a company that uses artificial intelligence to discover drugs for rare diseases, told Reuters Health by email the new drug targets and mechanisms of action identified by the researchers
